Logo - springer
Slogan - springer

| Clinical Pharmacokinetics – incl. option to publish open access (Editorial Board)

Clinical Pharmacokinetics

Clinical Pharmacokinetics

Editor: Amitabh Prakash
Associate Editor: Anton van Rensburg

ISSN: 0312-5963 (print version)
ISSN: 1179-1926 (electronic version)

Journal no. 40262

Editorial Board:

F. Akhlaghi, University of Rhode Island, Kingston, USA

K.M. Allegaert, University of Leuven, Leuven, Belgium

G.D. Anderson, University of Washington, Seattle, WA, USA

J.H. Beijnen, Utrecht University, Amsterdam, the Netherlands

H.R. Brunner, University of Lausanne, Lausanne, Switzerland

E. Chatelut, Institut Universitaire du Cancer Toulouse, Toulouse, France

M.-L. Chen, Food and Drug Administration, Silver Spring, MD, USA

S.J. Clarke, Royal North Shore Hospital, Sydney, NSW, Australia

J.L. Clements, Presbyterian College School of Pharmacy, Clinton, SC, USA

M.L. Dahl, Karolinska Institutet, Uppsala, Sweden

N.M. Davies, University of Alberta, Edmonton, AB, Canada

H. Derendorf, University of Florida, Gainesville, FL, USA

C.L. DeVane, Medical University of South Carolina, Charleston, SC, USA

S.N. de Wildt, Radboud University, Nijmegen, the Netherlands

T.C. Dowling, Ferris State University, Grand Rapids, MI, USA 

S. Duffull, University of Otago, Dunedin, New Zealand

C.B. Eap, Hopital de Cery, Lausanne, Switzerland

H. Echizen, Meiji Pharmaceutical University, Tokyo, Japan

A.N. Edginton, University of Waterloo, Waterloo, ON, Canada

E. Eliasson, Karolinska University Hospital, Stockholm, Sweden

M.H. Ensom, University of British Columbia, Vancouver, BC, Canada

A. Ferro, King's College London, London, UK

B. Green, University of Queensland, Brisbane, QLD, Australia

S. Harirforoosh, East Tennessee State University, Johnson City, TN, USA

G. Hempel, Wilhelms-Universität Munster, Muster, Germany

R.W. Jelliffe, University of Southern California, Los Angeles, CA, USA

C. Kloft, Freie Universitaet Berlin, Berlin, Germany

C.A.J. Knibbe, Leiden University, Leiden; and St. Antonius Hospital, Nieuwegein, the Netherlands

J. Lötsch, Johann Wolfgang Goethe-University, Frankfurt, Germany

B. Meibohm, University of Tennessee, Memphis, TN, USA

F. Mentré, Universite Paris Diderot, Paris, France

G. Mikus, University of Heidelberg, Heidelberg, Germany

G.D. Morse, University of Buffalo, Buffalo, NY, USA

P.J. Neuvonen, University of Helsinki, Helsinki, Finland

F. Pea, University of Udine, Udine, Italy

E. Perucca, University of Pavia, Pavia, Italy

J.H. Proost, University of Groningen, Groningen, the Netherlands

M.S. Roberts, University of Queensland, Brisbane, QLD, Australia

A. Sánchez Navarro, Universidad de Salamanca, Salamanca, Spain

C.M.T. Sherwin, University of Utah, Salt Lake City, UT, USA

S. Tett, University of Queensland, Brisbane, QLD, Australia

M. Tod, Université Lyon, Paris, France

D.J. Touw, University Medical Center Groningen,  Groningen, the Netherlands

V.V. Upreti, Amgen, CA, USA

J.N. vanden Anker, Children’s National Health System, Washington, DC, USA, and University Children’s Hospital, Basel, Switzerland

T. van Gelder, Erasmus Medical Center, Rotterdam, the Netherlands

Read this Journal on Springerlink

For authors and editors

  • Journal Citation Reports®
    2016 Impact Factor
  • 5.216
  • Aims and Scope

    Aims and Scope


    Clinical Pharmacokinetics promotes the continuing development of clinical pharmacokinetics and pharmacodynamics, for the improvement of drug therapy and to further postgraduate education in clinical pharmacology and therapeutics, by publishing critical and comprehensive review articles and clinically focussed original research articles. The Journal includes:

    • Leading articles/current opinions providing an overview of emerging areas and contentious issues;
    • clinical pharmacokinetics and relevant pharmacodynamics of both single drugs and drug classes;
    • pharmacokinetic principles behind effective drug treatment of particular diseases;
    • new concepts and principles in pharmacokinetics;
    • application of therapeutic drug monitoring to optimize therapy;
    • prediction and avoidance of drug interactions;
    • new methodology in drug development and advances in drug delivery systems;
    • optimization of treatment for particular patient populations;
    • regulatory aspects of pharmacokinetics and pharmacodynamics, with their practical implications.

    Articles published in Clinical Pharmacokinetics may be accompanied by plain language summaries to assist patients, caregivers  and others in understanding important medical advances

    All manuscripts are subject to peer review by international experts. Letters to the Editor are welcomed and will be considered for publication.

  • Submit Online
  • Open Choice - Your Way to Open Access
  • Instructions for Authors

    Instructions for Authors


  • Important Information for Authors

    Important Information for Authors’


  • Conflict of Interest form (doc, 84 kB)
  • Copyright Information

    Copyright Information


    Copyright Information

    For Authors

    Submission of a manuscript implies: that the work described has not been published before (except in form of an abstract or as part of a published lecture, review or thesis); that it is not under consideration for publication elsewhere; that its publication has been approved by all co-authors, if any, as well as – tacitly or explicitly – by the responsible authorities at the institution where the work was carried out.

    Author warrants (i) that he/she is the sole owner or has been authorized by any additional copyright owner to assign the right, (ii) that the article does not infringe any third party rights and no license from or payments to a third party is required to publish the article and (iii) that the article has not been previously published or licensed. The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors. Transfer of copyright to Springer (respective to owner if other than Springer) becomes effective if and when a Copyright Transfer Statement is signed or transferred electronically by the corresponding author. After submission of the Copyright Transfer Statement signed by the corresponding author, changes of authorship or in the order of the authors listed will not be accepted by Springer.

    The copyright to this article, including any graphic elements therein (e.g. illustrations, charts, moving images), is assigned for good and valuable consideration to Springer effective if and when the article is accepted for publication and to the extent assignable if assignability is restricted for by applicable law or regulations (e.g. for U.S. government or crown employees).

    The copyright assignment includes without limitation the exclusive, assignable and sublicensable right, unlimited in time and territory, to reproduce, publish, distribute, transmit, make available and store the article, including abstracts thereof, in all forms of media of expression now known or developed in the future, including pre- and reprints, translations, photographic reproductions and microform. Springer may use the article in whole or in part in electronic form, such as use in databases or data networks for display, print or download to stationary or portable devices. This includes interactive and multimedia use and the right to alter the article to the extent necessary for such use.

    Authors may self-archive the Author's accepted manuscript of their articles on their own websites. Authors may also deposit this version of the article in any repository, provided it is only made publicly available 12 months after official publication or later. He/she may not use the publisher's version (the final article), which is posted on SpringerLink and other Springer websites, for the purpose of self-archiving or deposit. Furthermore, the Author may only post his/her version provided acknowledgement is given to the original source of publication and a link is inserted to the published article on Springer's website. The link must be accompanied by the following text: "The final publication is available at link.springer.com".

    Prior versions of the article published on non-commercial pre-print servers like arXiv.org can remain on these servers and/or can be updated with Author's accepted version. The final published version (in pdf or html/xml format) cannot be used for this purpose. Acknowledgement needs to be given to the final publication and a link must be inserted to the published article on Springer's website, accompanied by the text "The final publication is available at link.springer.com". Author retains the right to use his/her article for his/her further scientific career by including the final published journal article in other publications such as dissertations and postdoctoral qualifications provided acknowledgement is given to the original source of publication.

    Author is requested to use the appropriate DOI for the article. Articles disseminated via link.springer.com are indexed, abstracted and referenced by many abstracting and information services, bibliographic networks, subscription agencies, library networks, and consortia.

    For Readers

    While the advice and information in this journal is believed to be true and accurate at the date of its publication, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may have been made. The publisher makes no warranty, express or implied, with respect to the material contained herein.

    All articles published in this journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article (e.g., as offprints), as well as all translation rights. No material published in this journal may be reproduced photographically or stored on microfilm, in electronic data bases, video disks, etc., without first obtaining written permission from the publisher (respective the copyright owner if other than Springer). The use of general descriptive names, trade names, trademarks, etc., in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

    Springer has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing Springer content. For permission to reuse our content please locate the material that you wish to use on link.springer.com or on springerimages.com and click on the permissions link or go to copyright.com, then enter the title of the publication that you wish to use. For assistance in placing a permission request, Copyright Clearance Center can be connected directly via phone: +1-855-239-3415, fax: +1-978-646-8600, or e-mail: info@copyright.com.

    © Springer International Publishing Switzerland

Alerts for this journal


Get the table of contents of every new issue published in Clinical Pharmacokinetics.

Additional information